Rontalizumab
Modify Date: 2024-11-05 11:44:58
Rontalizumab structure
|
Common Name | Rontalizumab | ||
|---|---|---|---|---|
| CAS Number | 948570-30-7 | Molecular Weight | 145.9 (kDa) | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of RontalizumabRontalizumab (RhuMab IFNalpha) is a humanized IgG1 monoclonal antibody targets IFN-α. Rontalizumab can be used for the research of systemic lupus erythematosus[1]. |
| Name | Rontalizumab |
|---|
| Description | Rontalizumab (RhuMab IFNalpha) is a humanized IgG1 monoclonal antibody targets IFN-α. Rontalizumab can be used for the research of systemic lupus erythematosus[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Weight | 145.9 (kDa) |
|---|